Cognitive functioning of postmenopausal breast cancer patients before adjuvant systemic therapy, and its association with medical and psychological factors

被引:31
|
作者
Schilder, C. M. T. [1 ]
Seynaeve, C. [2 ]
Linn, S. C. [3 ]
Boogerd, W. [4 ,5 ]
Beex, L. V. A. M. [6 ]
Gundy, C. M. [1 ]
Nortier, J. W. R. [7 ]
van de Velde, C. J. H. [8 ]
van Dam, F. S. A. M. [1 ]
Schagen, S. B. [1 ]
机构
[1] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Psychosocial Res & Epidemiol, NL-1066 CX Amsterdam, Netherlands
[2] Dr Daniel Den Hoed Canc Ctr, Dept Med Oncol, Erasmus Med Ctr, NL-3008 AE Rotterdam, Netherlands
[3] Netherlands Canc Inst, Dept Med Oncol, Amsterdam, Netherlands
[4] Netherlands Canc Inst, Dept Neurooncol, Amsterdam, Netherlands
[5] Slotervaart Med Ctr, Dept Neurol, Amsterdam, Netherlands
[6] Radboud Univ Nijmegen, Med Ctr, Dept Med Oncol, NL-6525 ED Nijmegen, Netherlands
[7] Leiden Univ, Med Ctr, Dept Clin Oncol, Leiden, Netherlands
[8] Leiden Univ, Med Ctr, Dept Surg Oncol, Leiden, Netherlands
关键词
Breast cancer; Postmenopausal; Cognitive function; Neuropsychological testing; Psychological function; Adjuvant systemic treatment; REPRODUCTIVE PERIOD; CHEMOTHERAPY; RISK; IMPAIRMENT; WOMEN; DYSFUNCTION; DEMENTIA; PEOPLE;
D O I
10.1016/j.critrevonc.2009.11.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: This study aimed to identify medical and psychological predictors for cognitive performance of breast cancer (BC) patients before the start of adjuvant systemic treatment and to compare cognitive performance between BC patients and healthy controls adjusting for medical and psychological variables. Material: 205 postmenopausal BC patients underwent pre-treatment neuropsychological tests and provided medical and psychological data. 124 healthy controls underwent the same assessment. Results: 'Treatment for diabetes mellitus' and/or 'hypertension', 'less hours spent on cognitively stimulating activities', 'fewer days since surgery' and 'more reproductive years' were associated with worse cognitive performance in the BC patients, independent of age and IQ. Cognitive differences between BC patients and healthy controls could partly be explained by the evaluated variables. Conclusion: The results stress the need for adjustment for pre-treatment cognitive differences between study groups, and also indicate that further research into pre-treatment cognitive dysfunction is warranted. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:133 / 141
页数:9
相关论文
共 50 条
  • [21] Target and reality of adjuvant endocrine therapy in postmenopausal patients with invasive breast cancer
    Gueth, U.
    Huang, D. J.
    Schoetzau, A.
    Zanetti-Daellenbach, R.
    Holzgreve, W.
    Bitzer, J.
    Wight, E.
    BRITISH JOURNAL OF CANCER, 2008, 99 (03) : 428 - 433
  • [22] Androgen levels during adjuvant endocrine therapy in postmenopausal breast cancer patients
    Baumgart, J.
    Nilsson, K.
    Evers, A. Stavreus
    Kallak, T. Kunovac
    Kushnir, M. M.
    Bergquist, J.
    Poromaa, I. Sundstrom
    CLIMACTERIC, 2014, 17 (01) : 48 - 54
  • [23] Target and reality of adjuvant endocrine therapy in postmenopausal patients with invasive breast cancer
    U Güth
    D J Huang
    A Schötzau
    R Zanetti-Dällenbach
    W Holzgreve
    J Bitzer
    E Wight
    British Journal of Cancer, 2008, 99 : 428 - 433
  • [24] A population-based study on variations in the use of adjuvant systemic therapy on postmenopausal patients with early stage breast cancer
    Nagel, G
    Röhrig, B
    Hoyer, H
    Wedding, U
    Katenkamp, D
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2003, 129 (03) : 183 - 191
  • [25] A population-based study on variations in the use of adjuvant systemic therapy on postmenopausal patients with early stage breast cancer
    G. Nagel
    B. Röhrig
    H. Hoyer
    U. Wedding
    D. Katenkamp
    Journal of Cancer Research and Clinical Oncology, 2003, 129 : 183 - 191
  • [26] Do All Patients with Breast Cancer Require Systemic Adjuvant Therapy?
    Griggs, Jennifer J.
    Hayes, Daniel F.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (18): : 1350 - 1351
  • [27] An update on adjuvant systemic therapy for elderly patients with early breast cancer
    Jerzak, Katarzyna J.
    Desautels, Danielle N.
    Pritchard, Kathleen I.
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (14) : 1881 - 1888
  • [28] Neuropsychological Functioning in Breast Cancer Patients Receiving Adjuvant Aromatase Inhibitor Therapy
    Weaver, J. R.
    Stark, S. M.
    Shaverdi, K. T.
    Jeter, S.
    Zorzi, J.
    Skolasky, R. L.
    Andrejczuk, M. A.
    Sterans, V
    Gordon, B.
    CLINICAL NEUROPSYCHOLOGIST, 2011, 25 (05) : 883 - 883
  • [29] Association between adjuvant regional radiotherapy and cognitive function in breast cancer patients treated with conservation therapy
    Shibayama, Osamu
    Yoshiuchi, Kazuhiro
    Inagaki, Masatoshi
    Matsuoka, Yutaka
    Yoshikawa, Eisho
    Sugawara, Yuriko
    Akechi, Tatsuo
    Wada, Noriaki
    Imoto, Shigeru
    Murakami, Koji
    Ogawa, Asao
    Akabayashi, Akira
    Uchitomi, Yosuke
    CANCER MEDICINE, 2014, 3 (03): : 702 - 709
  • [30] ENDOCRINE FACTORS IN THE OUTCOME OF SYSTEMIC ADJUVANT THERAPY OF EARLY BREAST-CANCER
    BIANCO, AR
    DEPLACIDO, S
    PERRONE, F
    CARLOMAGNO, C
    DELAURENTIIS, M
    DELMASTRO, L
    LAURIA, R
    MARINELLI, A
    GALLO, C
    BREAST CANCER: FROM BIOLOGY TO THERAPY, 1993, 698 : 330 - 338